Should we buy more???
whenever i turn my desk on, the value that cxr offers to new investors is just amazing. APPROX 50 MILLION shares outstanding . 30% of float or 13 million shares need to be covered. Strateguc review close to completion with a poteintial double or a triple. I guess buying this at 100$ us was stupid but under 10$ is a deal of a lifetime. Almost 500 million + in ebidita in 2016 and 145 million $ in cash. + 60 new products to be launched shortly with over 200 + other products on sale in 100 countries..mind boggling but i think new management could do wonders here...